Crispr Therapeutics shares owned by Baillie Gifford & Co
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Baillie Gifford & Co
from 13F filings
Historical chart of Baillie Gifford & Co investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Baillie Gifford & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Baillie Gifford & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $17M | 365k | 46.98 |
| 2024-06-30 | $22M | 405k | 54.01 |
| 2024-03-31 | $27M | 396k | 68.16 |
| 2023-12-31 | $27M | 423k | 62.60 |
| 2023-09-30 | $20M | 441k | 45.39 |
| 2023-06-30 | $14M | 244k | 56.14 |
| 2023-03-31 | $12M | 263k | 45.23 |
| 2022-12-31 | $11M | 263k | 40.65 |
| 2022-09-30 | $19M | 289k | 65.35 |